Bionik Laboratories Corp.
BNKL · OTC
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,787 | $4,286 | $2,078 | $6,880 |
| - Cash | $427 | $685 | $398 | $1,329 |
| + Debt | $2,412 | $1,863 | $1,037 | $503 |
| Enterprise Value | $4,772 | $5,464 | $2,717 | $6,054 |
| Revenue | $501 | $575 | $486 | $243 |
| % Growth | -12.9% | 18.3% | 100.2% | – |
| Gross Profit | $254 | $271 | $298 | $168 |
| % Margin | 50.7% | 47% | 61.2% | 69% |
| EBITDA | -$1,282 | -$1,026 | -$1,100 | -$1,367 |
| % Margin | -255.9% | -178.4% | -226.2% | -563.1% |
| Net Income | -$1,415 | -$1,109 | -$1,148 | -$1,395 |
| % Margin | -282.5% | -192.9% | -236% | -574.5% |
| EPS Diluted | -0.2 | -0.16 | -0.17 | -0.2 |
| % Growth | -25% | 5.9% | 15% | – |
| Operating Cash Flow | -$757 | -$513 | -$955 | -$1,162 |
| Capital Expenditures | -$1 | $50 | $50 | $0 |
| Free Cash Flow | -$758 | -$463 | -$905 | -$1,162 |